BANK VONTOBEL/CALL/NOVARTIS N/110/0.1/20.06.25 Share Price

Warrant

WNOADV

CH1312985430

Real-time Bid/Ask 04:48:30 21/05/2024 pm IST
0.174 CHF / 0.184 CHF +1.70% Intraday chart for BANK VONTOBEL/CALL/NOVARTIS N/110/0.1/20.06.25
Current month+33.33%
1 month+95.56%
Date Price Change
17/24/17 0.176 +4.76%
16/24/16 0.168 -8.70%
14/24/14 0.184 +10.84%
13/24/13 0.166 +3.75%

Delayed Quote Swiss Exchange

Last update May 17, 2024 at 08:50 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying NOVARTIS AG
IssuerLogo Issuer Vontobel Vontobel
WNOADV
ISINCH1312985430
Date issued 09/01/2024
Strike 110 CHF
Maturity 20/06/2025 (396 Days)
Parity 10 : 1
Emission price 0.14 CHF
Emission volume N/A
Settlement physical
Currency CHF

Technical Indicators

Highest since issue 0.206 CHF
Lowest since issue 0.086 CHF
Spread 0.01 CHF
Spread %5.32%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
102.9 USD
Average target price
108 USD
Spread / Average Target
+4.96%
Consensus
  1. Stock Market
  2. Warrants
  3. WNOADV Warrant
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW